Towards Healthcare
Cell and Gene Therapy Cold Chain Logistics Market to Rise at 15.64% CAGR till ...

Cell and Gene Therapy Cold Chain Logistics Market AI Adoption

Projections indicate that, the global cell and gene therapy cold chain logistics market will increase from USD 1.89 billion in 2024 to USD 8.06 billion by 2034, experiencing a CAGR of 15.64% over the next 10 years. The cell and gene therapy cold chain logistics market is expanding due to advancing cold chain technologies as well as increasing cell and gene therapy development. North America led the market due to the growth in the CGT approval rates.

Content

  • Insight Code: 6098
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The cell and gene therapy cold chain logistics market is worth USD 2.19 billion in 2025, and by 2034, it is forecasted to hit USD 8.06 billion, registering a CAGR of 15.64% over the decade.

North America is currently leading the cell and gene therapy cold chain logistics market due to the growth in the CGT approval rates.

The cell and gene therapy cold chain logistics market includes 5 segments such as by service type, by therapy type, by temperature range, by end user, and by region.

Some key players include Cryoport, Inc., World Courier, Marken, and Catalent Cell & Gene Therapy Logistics.

The rise in commercial approvals of CGTs is increasing the demand for reliable cold chain logistics to ensure product integrity, patient safety, and regulatory compliance.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions